Listed

Capricor Therapeutics, Inc.

CAPRNasdaqCIK 1133869HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$11.1m, Q4 FY2024
Operating income−$42.9m, Q2 FY2026
Net income−$40.7m, Q2 FY2026
Capricor Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m6.2Revenue, Q3 FY2023, three months to 2023-09-30$6.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure12.1Revenue, Q4 FY2023, three months to 2023-12-31$12.1m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-26, accession 0001558370-25-003707. Derived: 12-month figure less the 9-month figure.Report this figure4.9Revenue, Q1 FY2024, three months to 2024-03-31$4.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure4.0Revenue, Q2 FY2024, three months to 2024-06-30$4.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure2.3Revenue, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure11.1Revenue, Q4 FY2024, three months to 2024-12-31$11.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m10.0Research and development, Q3 FY2023, three months to 2023-09-30$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure9.9Research and development, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-26, accession 0001558370-25-003707. Derived: 12-month figure less the 9-month figure.Report this figure11.1Research and development, Q1 FY2024, three months to 2024-03-31$11.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure12.5Research and development, Q2 FY2024, three months to 2024-06-30$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure11.8Research and development, Q3 FY2024, three months to 2024-09-30$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure14.6Research and development, Q4 FY2024, three months to 2024-12-31$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure18.9Research and development, Q1 FY2025, three months to 2025-03-31$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure22.0Research and development, Q2 FY2025, three months to 2025-06-30$22.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure20.4Research and development, Q3 FY2025, three months to 2025-09-30$20.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure23.1Research and development, Q4 FY2025, three months to 2025-12-31$23.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure27.4Research and development, Q1 FY2026, three months to 2026-03-31$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure28.9Research and development, Q2 FY2026, three months to 2026-06-30$28.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Operating income$m(6.9)Operating income, Q3 FY2023, three months to 2023-09-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure(1.3)Operating income, Q4 FY2023, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-26, accession 0001558370-25-003707. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Operating income, Q1 FY2024, three months to 2024-03-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure(11.6)Operating income, Q2 FY2024, three months to 2024-06-30−$11.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure(13.0)Operating income, Q3 FY2024, three months to 2024-09-30−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure(7.7)Operating income, Q4 FY2024, three months to 2024-12-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure(25.0)Operating income, Q1 FY2025, three months to 2025-03-31−$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(27.7)Operating income, Q2 FY2025, three months to 2025-06-30−$27.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure(26.3)Operating income, Q3 FY2025, three months to 2025-09-30−$26.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure(29.2)Operating income, Q4 FY2025, three months to 2025-12-31−$29.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure(36.8)Operating income, Q1 FY2026, three months to 2026-03-31−$36.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(42.9)Operating income, Q2 FY2026, three months to 2026-06-30−$42.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$1.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figurenot reportednot reported0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$1.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Net income$m(6.4)Net income, Q3 FY2023, three months to 2023-09-30−$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure(0.8)Net income, Q4 FY2023, three months to 2023-12-31−$762.1k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-26, accession 0001558370-25-003707. Derived: 12-month figure less the 9-month figure.Report this figure(9.8)Net income, Q1 FY2024, three months to 2024-03-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure(11.0)Net income, Q2 FY2024, three months to 2024-06-30−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure(12.6)Net income, Q3 FY2024, three months to 2024-09-30−$12.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure(7.1)Net income, Q4 FY2024, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure(24.4)Net income, Q1 FY2025, three months to 2025-03-31−$24.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure(25.9)Net income, Q2 FY2025, three months to 2025-06-30−$25.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure(24.6)Net income, Q3 FY2025, three months to 2025-09-30−$24.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure(30.2)Net income, Q4 FY2025, three months to 2025-12-31−$30.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure(33.9)Net income, Q1 FY2026, three months to 2026-03-31−$33.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure(40.7)Net income, Q2 FY2026, three months to 2026-06-30−$40.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Diluted EPS$ per share(0.25)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure(0.35)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure(0.38)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figurenot reported(0.53)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(0.57)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure(0.54)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figurenot reported(0.59)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(0.70)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Basic EPS$ per share(0.25)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figurenot reported(0.31)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure(0.35)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure(0.38)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figurenot reported(0.53)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(0.57)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure(0.54)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figurenot reported(0.59)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(0.70)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure

Balance sheet

Cash and equivalents$20.9m, Q2 FY2026
Shareholders' equity$246.2m, Q2 FY2026
Capricor Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.0Cash and equivalents, Q3 FY2023, at 2023-09-30$9.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001558370-23-019065.Report this figure14.7Cash and equivalents, FY2023, at 2023-12-31$14.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-26, accession 0001558370-25-003707.Report this figure6.2Cash and equivalents, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001558370-24-008072.Report this figure10.7Cash and equivalents, Q2 FY2024, at 2024-06-30$10.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001558370-24-011638.Report this figure68.4Cash and equivalents, Q3 FY2024, at 2024-09-30$68.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure11.3Cash and equivalents, FY2024, at 2024-12-31$11.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001104659-26-029580.Report this figure28.8Cash and equivalents, Q1 FY2025, at 2025-03-31$28.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure23.2Cash and equivalents, Q2 FY2025, at 2025-06-30$23.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure19.5Cash and equivalents, Q3 FY2025, at 2025-09-30$19.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure288Cash and equivalents, FY2025, at 2025-12-31$287.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure105Cash and equivalents, Q1 FY2026, at 2026-03-31$105.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure20.9Cash and equivalents, Q2 FY2026, at 2026-06-30$20.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Current assets$m29.5Current assets, Q3 FY2023, at 2023-09-30$29.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019065.Report this figure50.9Current assets, FY2023, at 2023-12-31$50.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-26, accession 0001558370-25-003707.Report this figure41.4Current assets, Q1 FY2024, at 2024-03-31$41.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008072.Report this figure30.7Current assets, Q2 FY2024, at 2024-06-30$30.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011638.Report this figure85.8Current assets, Q3 FY2024, at 2024-09-30$85.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure163Current assets, FY2024, at 2024-12-31$163.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-17, accession 0001104659-26-029580.Report this figure146Current assets, Q1 FY2025, at 2025-03-31$146.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure124Current assets, Q2 FY2025, at 2025-06-30$124.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure101Current assets, Q3 FY2025, at 2025-09-30$101.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure323Current assets, FY2025, at 2025-12-31$322.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure283Current assets, Q1 FY2026, at 2026-03-31$283.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure242Current assets, Q2 FY2026, at 2026-06-30$242.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Total assets$m37.2Total assets, Q3 FY2023, at 2023-09-30$37.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-019065.Report this figure58.7Total assets, FY2023, at 2023-12-31$58.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-26, accession 0001558370-25-003707.Report this figure49.4Total assets, Q1 FY2024, at 2024-03-31$49.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001558370-24-008072.Report this figure38.3Total assets, Q2 FY2024, at 2024-06-30$38.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011638.Report this figure93.0Total assets, Q3 FY2024, at 2024-09-30$93.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure170Total assets, FY2024, at 2024-12-31$170.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-17, accession 0001104659-26-029580.Report this figure154Total assets, Q1 FY2025, at 2025-03-31$153.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure134Total assets, Q2 FY2025, at 2025-06-30$133.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure126Total assets, Q3 FY2025, at 2025-09-30$126.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure356Total assets, FY2025, at 2025-12-31$355.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure326Total assets, Q1 FY2026, at 2026-03-31$326.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure369Total assets, Q2 FY2026, at 2026-06-30$368.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Current liabilities$m32.9Current liabilities, Q3 FY2023, at 2023-09-30$32.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019065.Report this figure31.3Current liabilities, FY2023, at 2023-12-31$31.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-26, accession 0001558370-25-003707.Report this figure26.4Current liabilities, Q1 FY2024, at 2024-03-31$26.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008072.Report this figure22.4Current liabilities, Q2 FY2024, at 2024-06-30$22.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011638.Report this figure20.5Current liabilities, Q3 FY2024, at 2024-09-30$20.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure21.0Current liabilities, FY2024, at 2024-12-31$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-17, accession 0001104659-26-029580.Report this figure22.3Current liabilities, Q1 FY2025, at 2025-03-31$22.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure28.4Current liabilities, Q2 FY2025, at 2025-06-30$28.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure28.1Current liabilities, Q3 FY2025, at 2025-09-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure35.8Current liabilities, FY2025, at 2025-12-31$35.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure33.6Current liabilities, Q1 FY2026, at 2026-03-31$33.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure33.0Current liabilities, Q2 FY2026, at 2026-06-30$33.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Total liabilities$m38.9Total liabilities, Q3 FY2023, at 2023-09-30$38.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-019065.Report this figure36.1Total liabilities, FY2023, at 2023-12-31$36.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-26, accession 0001558370-25-003707.Report this figure31.0Total liabilities, Q1 FY2024, at 2024-03-31$31.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001558370-24-008072.Report this figure26.8Total liabilities, Q2 FY2024, at 2024-06-30$26.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001558370-24-011638.Report this figure24.7Total liabilities, Q3 FY2024, at 2024-09-30$24.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure25.0Total liabilities, FY2024, at 2024-12-31$25.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-17, accession 0001104659-26-029580.Report this figure26.1Total liabilities, Q1 FY2025, at 2025-03-31$26.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure28.6Total liabilities, Q2 FY2025, at 2025-06-30$28.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure42.6Total liabilities, Q3 FY2025, at 2025-09-30$42.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure50.2Total liabilities, FY2025, at 2025-12-31$50.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure47.6Total liabilities, Q1 FY2026, at 2026-03-31$47.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure123Total liabilities, Q2 FY2026, at 2026-06-30$122.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure
Shareholders' equity$m(1.8)Shareholders' equity, Q3 FY2023, at 2023-09-30−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure22.6Shareholders' equity, FY2023, at 2023-12-31$22.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-17, accession 0001104659-26-029580.Report this figure18.4Shareholders' equity, Q1 FY2024, at 2024-03-31$18.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure11.5Shareholders' equity, Q2 FY2024, at 2024-06-30$11.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure68.3Shareholders' equity, Q3 FY2024, at 2024-09-30$68.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure145Shareholders' equity, FY2024, at 2024-12-31$145.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure128Shareholders' equity, Q1 FY2025, at 2025-03-31$127.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure105Shareholders' equity, Q2 FY2025, at 2025-06-30$105.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure83.9Shareholders' equity, Q3 FY2025, at 2025-09-30$83.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure306Shareholders' equity, FY2025, at 2025-12-31$305.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure279Shareholders' equity, Q1 FY2026, at 2026-03-31$278.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure246Shareholders' equity, Q2 FY2026, at 2026-06-30$246.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure

Cash flow

Operating cash flow−$31.5m, Q2 FY2026
Capital expenditure$4.1m, Q2 FY2026
Capricor Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001558370-24-015730. Derived: 9-month figure less the 6-month figure.Report this figure(11.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-26, accession 0001558370-25-003707. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure(12.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001558370-25-011084. Derived: 6-month figure less the 3-month figure.Report this figure(11.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-109298. Derived: 9-month figure less the 6-month figure.Report this figure(14.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure(6.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(20.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001104659-26-097294. Derived: 6-month figure less the 3-month figure.Report this figure(19.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-109298. Derived: 9-month figure less the 6-month figure.Report this figure(23.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure(29.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$29.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure(31.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$31.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001104659-26-097294. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$269.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001558370-24-015730. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$558.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-26, accession 0001558370-25-003707. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$608.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$60.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001558370-25-011084. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001104659-25-109298. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$488.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure0.9Capital expenditure, Q1 FY2025, three months to 2025-03-31$896.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure0.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$287.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001104659-26-097294. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$55.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001104659-25-109298. Derived: 9-month figure less the 6-month figure.Report this figure1.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001104659-26-029580. Derived: 12-month figure less the 9-month figure.Report this figure5.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure4.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001104659-26-097294. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)57.93m, Q2 FY2026
Capricor Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares24.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3024,431,787 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-019065.Report this figure25.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3125,247,354 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001558370-24-008072.Report this figure25.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3025,335,342 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001558370-24-011638.Report this figure25.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3025,817,676 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001558370-24-015730.Report this figure31.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3131,354,629 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001558370-25-007770.Report this figure31.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3031,841,964 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001558370-25-011084.Report this figure33.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3033,090,063 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure45.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3145,636,633 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure45.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3045,709,071 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure45.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3045,716,151 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-109298.Report this figure57.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3157,434,267 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001104659-26-060382.Report this figure57.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3057,926,347 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure

Shares outstanding: 58.14mShares outstanding, period not labelled, at 2026-08-1358,138,989 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001104659-26-097294.Report this figure at Aug 13, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.